AAAAAA

   
Results: 1-7 |
Results: 7
DOMESTIC SAVINGS, PUBLIC SAVINGS AND EXPENDITURES ON CONSUMER DURABLEGOODS IN ARGENTINA
Authors: MURPHY RL NAVAJAS F
Citation: Rl. Murphy et F. Navajas, DOMESTIC SAVINGS, PUBLIC SAVINGS AND EXPENDITURES ON CONSUMER DURABLEGOODS IN ARGENTINA, Journal of development economics, 57(1), 1998, pp. 97-116
A COMPARATIVE TRIAL OF ZIDOVUDINE ADMINISTERED EVERY 4 VERSUS EVERY 12 HOURS FOR THE TREATMENT OF ADVANCED HIV DISEASE
Authors: SHEPP DH RAMIREZRONDA C DALL L POLLARD RB MURPHY RL KESSLER H SHERER R MERTZ G PEREZ G GOCKE DJ GREENBERG SB PETERSEN E FRANK I MOORE MD MCKINNIS R ROONEY JF
Citation: Dh. Shepp et al., A COMPARATIVE TRIAL OF ZIDOVUDINE ADMINISTERED EVERY 4 VERSUS EVERY 12 HOURS FOR THE TREATMENT OF ADVANCED HIV DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 15(4), 1997, pp. 283-288
IDENTIFICATION OF AMDX, A NEW CYS-2-HIS-2 (C2H2) ZINC-FINGER GENE INVOLVED IN THE REGULATION OF THE AMDS GENE OF ASPERGILLUS-NIDULANS
Authors: MURPHY RL ANDRIANOPOULOS A DAVIS MA HYNES MJ
Citation: Rl. Murphy et al., IDENTIFICATION OF AMDX, A NEW CYS-2-HIS-2 (C2H2) ZINC-FINGER GENE INVOLVED IN THE REGULATION OF THE AMDS GENE OF ASPERGILLUS-NIDULANS, Molecular microbiology, 23(3), 1997, pp. 591-602
THE ACETATE REGULATORY GENE FACB OF ASPERGILLUS-NIDULANS ENCODES A ZN(II)2CYS6 TRANSCRIPTIONAL ACTIVATOR
Authors: TODD RB MURPHY RL MARTIN HM SHARP JA DAVIS MA KATZ ME HYNES MJ
Citation: Rb. Todd et al., THE ACETATE REGULATORY GENE FACB OF ASPERGILLUS-NIDULANS ENCODES A ZN(II)2CYS6 TRANSCRIPTIONAL ACTIVATOR, MGG. Molecular & general genetics, 254(5), 1997, pp. 495-504
ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE
Authors: DOLIN R AMATO DA FISCHL MA PETTINELLI C BELTANGADY M LIOU SH BROWN MJ CROSS AP HIRSCH MS HARDY WD MILDVAN D BLAIR DC POWDERLY WG PARA MF FIFE KH STEIGBIGEL RT SMALDONE L CRUMPACKER CS COOLEY T MITSUYASO RT JOHN R SANDERS C REITMAN D HEWITT R REICHMAN RC GELB LD MCGUIRE ML JONES M NEIDIG JL ZWICKL B HARTMAN PB ROARKE ME BURK RA FUHRER J SOMOGYI KA SEPKOWITZ K TELZAK EE MCAULIFFE VJ VALENTINE FT VASQUEZ M MERIGAN TC KATZENSTEIN D FESSELL J HAVLIR DV RICHMAN DD SPECTOR SA KAHN JO JOHNSON L COLEMAN R HO M MCMAHON D PAZIN G ANTONISKIS D MCNAMARA B DIAMOND D COLLIER AC PARADISE MA WALD A DEPAOLISJONES A HENRY K WASKIN HA HYSLOP NE MUSHATT DM ZACHARY JA SOEIRO R HARRIS C ZINGMAN B GIORDANO MF SLEDZ S MURRAY HW CAREY JT DAVIS TL BAGBY B KESSLER HA MURPHY RL HIRSCHTICK RE CHEESEMAN SH LAI KK FAIRCHILD PG EHMANN WC ZURLO JJ MILLARD R TROIANI L HEGGEN AA VANDERHORST CM MCKINLEY GF GRIECO MH KOLATCH BR GOLDSMITH JC GOMPERTS ED WOODS LM GRUE L MAYJO K BECKER RL JAYAWEERA DT ROLFE L COLE J JERMANO J
Citation: R. Dolin et al., ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE, Archives of internal medicine, 155(9), 1995, pp. 961-974
CLINDAMYCIN AND PRIMAQUINE THERAPY FOR MILD-TO-MODERATE EPISODES OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS - AIDS CLINICAL-TRIALS GROUP-044
Authors: BLACK JR FEINBERG J MURPHY RL FASS RJ FINKELSTEIN D AKIL B SAFRIN S CAREY JT STANSELL J PLOUFFE JF HE WL SHELTON B SATTLER FR
Citation: Jr. Black et al., CLINDAMYCIN AND PRIMAQUINE THERAPY FOR MILD-TO-MODERATE EPISODES OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS - AIDS CLINICAL-TRIALS GROUP-044, Clinical infectious diseases, 18(6), 1994, pp. 905-913
PHASE-II DOSE-RANGING TRIAL OF FOSCARNET SALVAGE THERAPY FOR CYTOMEGALOVIRUS RETINITIS IN AIDS PATIENTS INTOLERANT OF OR RESISTANT TO GANCICLOVIR (ACTG PROTOCOL 093)
Authors: JACOBSON MA WULFSOHN M FEINBERG JE DAVIS R POWER M OWENS S CAUSEY D HEATHCHIOZZI ME MURPHY RL CHEUNG TW DIETERICH DT SPECTOR SA MCKINLEY GF PARENTI DM CRUMPACKER C NISHIMOTO B LEEDOM JM KRAMER F COHEN C LOFTUS J KESSLER HA POTTAGE JC BENSON CA PHAIR JP GERITS P CHUSID E SACKS HS FRIEDBERG D CURRANKRIKORIAN K VALENTINE FT MENG TC FREEMAN WR MEIXNER L RICHMAN D ODONNELL JJ KIMBRELL C BOGGIO K LARSON J WHITMORE PV SIMON GL LELACHEUR S FIFE K ZWICKL B RELUE J STEIGBIGEL RT FUHRER J DONLON W BURK RA PORTMORE AC WEISSBACH NE HOOTON TM HOLZWORTH P DAVISON S COLLIER AC POWDERLY WG KLEBERT M ROYAL M SEYFRIED W SQUIRES KC WEISS W BARBACCI M BECKER RL JABS D BARTLETT JG PARA MF JONES M NEIDIG JL FASS RJ VANDERHORST C KYLSTRA J RAASCH R BLOODGOOD K WOLITZ R KIRK S ROLFE L PATRONEREESE J BARTLETT JA WASKIN HA WILLIAMS DK SHIP KW KAHL P ASSAYKEEN T KAROL C MARTINMUNLEY S SUMNER P
Citation: Ma. Jacobson et al., PHASE-II DOSE-RANGING TRIAL OF FOSCARNET SALVAGE THERAPY FOR CYTOMEGALOVIRUS RETINITIS IN AIDS PATIENTS INTOLERANT OF OR RESISTANT TO GANCICLOVIR (ACTG PROTOCOL 093), AIDS, 8(4), 1994, pp. 451-459
Risultati: 1-7 |